stockportfolio.pro
Stocks / AVAH vs PRCT
AVAH vs PRCT
Aveanna Healthcare Holdings Inc. and PROCEPT BioRobotics Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Aveanna Healthcare Holdings Inc. (AVAH) | PROCEPT BioRobotics Corporation (PRCT) | |
|---|---|---|
| Market cap | $1.5B | $1.5B |
| Revenue (latest FY) | $2.43B | $308.05M |
| Net income (latest FY) | $225.03M | $-95.57M |
| Revenue growth (5y CAGR) | 10.2% | 109.0% |
| Net margin | 9.2% | -31.0% |
| Return on equity | 115.3% | -26.1% |
| P/E ratio | 5.8 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open AVAH — free Open PRCT — freeFrequently asked questions
Which is bigger, AVAH or PRCT?
PROCEPT BioRobotics Corporation is larger by market capitalization — $1.5B versus $1.5B.
Which grows faster, AVAH or PRCT?
Over the last five fiscal years, PROCEPT BioRobotics Corporation grew revenue faster — 109.0%/yr versus 10.2%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.